Info@ThinkPinkRocks.com

Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Add a Comment By Jim Stallard, MA, Writer/Editor   |  Wednesday, March 20, 2013 Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

See more here:
Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Share

Leave a Reply